Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Gush who wrote (11775)	2/12/1999 2:13:00 AM
From: pitchlyn	Respond to of 25711

Late but GREAT NEWS for EYDY!!! Will move it for sure, tomorrow!!! Very late but, nevertheless, STUNNING NEWS for EYDY!!! Eye Dynamics Performed Best According to Government Funded Study PR Newswire - February 11, 1999 21:01 TORRANCE, Calif., Feb. 11 /PRNewswire/ -- Eye Dynamics (OTC Bulletin Board: EYDY) reveals for the first time that its technology for evaluating impairment in individuals was 3x more accurate than any other system evaluated by researcher Battelle in a study funded by the transportation Research Board. The product is the EPS-100 Eye Performance System and is the subject of a U.S. and several foreign patents. It evaluates a person's involuntary eye movements and pupil reactions based on techniques used by law enforcement throughout the United States and corroborated by medical science. The EPS-100 is a non-invasive computer based technology which establishes, in a mere 90 seconds, that an individual is impaired from drugs, alcohol, over-the-counter medications, prescriptions, certain medical conditions, or even physiological states like extreme fatigue. The Transportation Research Board (TRB) is a federal program jointly sponsored by the National Academy of Sciences, Federal Transit Administration and the Transit Development Corporation, Inc. The TRB chose Battelle as prime contractor in an evaluation of several emerging or commercially available systems to evaluate fitness-for-duty testing in the transportation industry. The Southern California Research Institute, in Los Angeles, performed the clinical trials using alcohol as the impairing agent. Of all the systems tested, Eye Dynamics' EPS-100 was 3x more accurate than any other product at a blood alcohol level (BAC) of .08%. A BAC of .10% is the legal limit for driving in most states. The final report is entitled "Fitness-For-Duty Testing in the Transit Workplace (TCRP F-01)" and is available for loan from the TRB in Washington, D.C. Eye Dynamics currently manufactures and markets medical devices, based on its patented technology, to customers around the world. Its R&D effort on the EPS-100 is moving forward with the goal of becoming an alternative to urine-based drug testing, a market which exceeds $1 Billion annually. FOR FURTHER INFORMATION CONTACT: Eye Dynamics, Inc. Phone: 800-376-4598 2301 W. 205th St., #106 FAX: 310-328-0697 Torrance, CA 90501 SOURCE Eye Dynamics, Inc. /CONTACT: Eye Dynamics, Inc., 800-376-4598, or fax, 310-328-0697/ (EYDY)